Jane Street’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Buy |
+103,296
| New | +$2.97M | ﹤0.01% | 1770 |
|
|
2025
Q1 | – | Sell |
-7,404
| Closed | -$379K | – | 5725 |
|
|
2024
Q4 | $379K | Sell |
7,404
-122,188
| -94% | -$6.25M | ﹤0.01% | 4339 |
|
|
2024
Q3 | $6.62M | Buy |
129,592
+9,712
| +8% | +$496K | ﹤0.01% | 1053 |
|
|
2024
Q2 | $5.37M | Buy |
119,880
+82,956
| +225% | +$3.72M | ﹤0.01% | 1615 |
|
|
2024
Q1 | $1.73M | Sell |
36,924
-66,110
| -64% | -$3.09M | ﹤0.01% | 2497 |
|
|
2023
Q4 | $3.67M | Buy |
103,034
+90,222
| +704% | +$3.21M | ﹤0.01% | 1810 |
|
|
2023
Q3 | $381K | Sell |
12,812
-9,308
| -42% | -$277K | ﹤0.01% | 3844 |
|
|
2023
Q2 | $399K | Buy |
+22,120
| New | +$399K | ﹤0.01% | 3967 |
|
|
2022
Q2 | – | Sell |
-14,936
| Closed | -$328K | – | 5627 |
|
|
2022
Q1 | $328K | Buy |
+14,936
| New | +$328K | ﹤0.01% | 4225 |
|
|
2020
Q3 | – | Sell |
-18,194
| Closed | -$319K | – | 3830 |
|
|
2020
Q2 | $319K | Buy |
+18,194
| New | +$319K | ﹤0.01% | 2986 |
|